Clinical significance of the positive surgical margin based upon location, grade, and stage

Urologic Oncology: Seminars and Original Investigations

Volumn 28, Issue 2, 2010, Pages 197-204

  Fleshner, Neil E ^a   Evans, Andrew ^a   Chadwick, Karen ^b   Lawrentschuk, Nathan ^b   Zlotta, Alexandre ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Operative surgical procedures; Outcome assessment; Pathology; Prostate neoplasm; Prostatectomy; Urology

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SALVAGE THERAPY; TUMOR VOLUME;

HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 77249123412     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.08.015     Document Type: Review

References (98)

1. American Cancer Society. Cancer Facts and Figures 2007 (2007), American Cancer Society, Atlanta (GA)
2. Cooperberg M.R., Broering J.M., Litwin M.S., et al., CaPSURE Investigators. The contemporary management of prostate cancer in the United States: Lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry. J Urol 171 (2004) 1393-1401
3. Bill-Axelson A., Holmberh L., Ruutu M., et al. Radical prostatectomy vs. watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
4. Bott S.R., and Kirby R.S. Avoidance and management of positive surgical margins before, during, and after radical prostatectomy. Prostate Cancer Prostatic Dis 5 (2002) 252-263
5. Ohori M., Wheeler T.M., Kattan M.W., et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154 (1995) 1818-1824
6. Srigley J, Amin MB, Humphreys PA, for the Members of the Cancer Committee College of American Pathologists. Prostate 2006. Northfield (IL): College of American Pathologists [cited Oct 2005].
7. Ward J.F., Zincke H., Bergstralh E.J., et al. The impact of surgical approach (nerve bundle preservation vs. wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol 172 4 Pt 1 (2004) t-32
8. Karakiewicz P.I., Eastham J.A., Graefen M., et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5,831 patients. Urology 66 (2005) 1245-1250
9. Eastham J.A., Kattan M.W., Riedel E., et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 170 6 Pt 1 (2003) t5
10. Chun F.K., Briganti A., Antebi E., et al. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. BJU Int 98 (2006) 1204-1209
11. Blute M.L., Bostwick D.G., Bergstralh E.J., et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 50 (1997) 733-739
12. Khan M.A., Partin A.W., Mangold L.A., et al. Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer. Urology 62 (2003) 866-871
13. Bianco Jr. F.J., Riedel E.R., Begg C.B., et al. Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters. J Urol 173 (2005) 2099-2103
14. Freedland S.J., Aronson W., Presti Jr. J.C., et al. Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3?. Results from the SEARCH database. J Urol 169 (2003) 2142-2146
15. Swindle P., Eastham J.A., Ohori M., et al. Do margins matter?. The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 174 (2005) 903-907
16. Palisaar R.J., Noldus J., Graefen M., et al. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure. Eur Urol 47 (2005) 176-184
17. Orvieto M.A., Alsikafi N.F., Shalhav A.L., et al. Impact of surgical margin status on long-term cancer control after radical prostatectomy. BJU Int 98 (2006) 1199-1203
18. Berger A.P., Volgger H., Rogatsch H., et al. Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens. Prostate 53 (2002) 24-25
19. Kausik S.J., Blute M.L., Sebo T.J., et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer 95 (2002) 1215-1219
20. Marcovich R., Wojno K.J., Wei J.T., et al. Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer. Urology 55 (2000) 904-908
21. Sofer M., Hamilton-Nelson K.L., Civantos F., et al. Positive surgical margins after radical retropubic prostatectomy: The influence of site and number on progression. J Urol 167 (2002) 2453-2456
22. Sofer M., Hamilton-Nelson K.L., Schlesselman J.J., et al. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. J Clin Oncol 20 (2002) 1853-1858
23. Fesseha T., Sakr W., Grignon D., et al. Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol 158 (1997) 2176-2179
24. Salomon L., Anastasiadis A.G., Antiphon P., et al. Prognostic consequences of the location of positive surgical margins in organ-confined prostate cancer. Urol Int 70 (2003) 291-296
25. Lepor H., and Kaci L. Role of intraoperative biopsies during radical retropubic prostatectomy. Urology 63 (2004) 499-502
26. Pettus J.A., Weight C.J., Thompson C.J., et al. Biochemical failure in men following radical retropubic prostatectomy: Impact of surgical margin status and location. J Urol 172 (2004) 129-132
27. Cannon Jr. G.M., Pound C.R., Landsittel D.P., et al. Perineural invasion in prostate cancer biopsies is not associated with higher rates of positive surgical margins. Prostate 63 (2005) 336-340
28. Rapp D.E., Orvieto M.A., Lucioni A., et al. Intraoperative prostate examination: Predictive value and effect on margin status. BJU Int 96 (2005) 1005-1008
29. Cohn J.H., and El-Galley R. Radical prostatectomy in a community practice. J Urol 167 (2002) 224-228
30. Emerson R.E., Koch M.O., Jones T.D., et al. The influence of extent of surgical margin positivity on prostate specific antigen recurrence. J Clin Pathol 58 (2005) 1028-1032
31. Cheng L., Slezak J., Bergstralh E.J., et al. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Oncol 18 (2000) 2862-2868
32. Graefen M., Hammerer P., Michl U., et al. Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. Urology 51 (1998) 437-442
33. Vis A.N., Schroder F.H., and van der Kwast T.H. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 50 (2006) 258-265
34. Rabbani F., Bastar A., and Fair W.R. Site-specific predictors of positive margins at radical prostatectomy: An argument for risk based modification of technique. J Urol 160 (1998) 1727-1733
35. Hsu E.I., Hong E.K., and Lepor H. Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy. Urology 61 (2003) 601-606
36. Lowe B.A. Comparison of bladder neck preservation to bladder neck resection in maintaining post-prostatectomy urinary continence. Urology 48 (1996) 889-893
37. Lee D.K., Allareddy V., O'donnell M.A., et al. Does the interval between prostate biopsy and radical prostatectomy affect the immediate postoperative outcome?. BJU Int 97 (2006) 48-50
38. Aydin H., Tsuzuki T., Hernandez D., et al. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression. Urology 64 (2004) 551-555
39. Deliveliotis C., Protogerou V., Alargof E., et al. Radical prostatectomy: Bladder neck preservation and puboprostatic ligament sparing-effects on continence and positive margins. Urology 60 (2002) 855-858
40. Alsikafi N.F., and Brendler C.B. Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins. J Urol 159 (1998) 1281-1285
41. Salomon L., Anastasiadis A.G., Johnson C.W., et al. Seminal vesicle involvement after radical prostatectomy: Predicting risk factors for progression. Urology 62 (2003) 304-309
42. Richman M., McLaughlin S., Maygarden S., et al. Initial incision of lateral pelvic fascia and early ligation of vascular pedicles during radical prostatectomy: Potential to reduce positive margin rates. BJU Int 95 (2005) 40-45
43. Guillonneau B., Cathelineau X., Doublet J.D., et al. Laparoscopic radical prostatectomy: Assessment after 550 procedures. Crit Rev Oncol Hematol 43 (2002) 123-133
44. Guilloneau B., el-Fettouh H., Baumert H., et al. Laparoscopic radical prostatectomy: Oncological evaluation after 1,000 cases a Montsouris Institute. J Urol 169 (2003) 1261-1266
45. Martinez-Pineiro L., Caceres F., Sanchez C., et al. Learning curve of laparoscopic radical prostatectomy in a university teaching hospital: Experience after the first 600 cases. Eur Urol 5 Suppl (2006) 914-924
46. Chuang A.Y., Nielsen M.E., Hernandez D.J., et al. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. J Urol 178 4 Pt 1 (2007) 1306-1310
47. Grossfeld G., Tigrani V.S., Nudell D., et al. Management of positive surgical margins after radical prostatectomy. Decision analysis. J Urol 164 (2000) 93-100
48. Polascik T.J., Pearson J.D., and Partin A.W. Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen. Semin Urol Oncol 16 (1998) 160-171
49. Stamey T.A., Caldwell M., McNeal J.E., et al. The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?. J Urol 172 4 Pt 1 (2004) 1297-1301
50. Graif T., Loeb S., Roehl K.A., et al. Under diagnosis and over diagnosis of prostate cancer. J Urol 178 (2007) 88-92
51. Nelson B.A., Shappell S.B., Chang S.S., et al. Tumor volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 97 (2006) 1169-1172
52. Buschemeyer III W.C., and Freedland S.J. Obesity and prostate cancer: Epidemiology and clinical implications. Eur Urol 52 (2007) 331-343
53. Castle E.P., Atug F., Woods M., et al. Impact of body mass index on outcomes after robot assisted radical prostatectomy. World J Urol 26 (2008) 91-95
54. Matsunaga G.S., Ahlering T.E., and Skarecky D.W. Update on robotic laparoscopic radical prostatectomy. Scientific World J 6 (2006) 2542-2552
55. Martorana G., Manferrari F., Bertaccini A., et al. Laparoscopic radical prostatectomy: Oncological evaluation in the early phase of the learning curve comparing to retropubic approach. Arch Ital Urol Androl 76 (2004) 1-5
56. El-Feel A., Davis J.W., Deger S., et al. Positive margins after laparoscopic radical prostatectomy: A prospective study of 100 cases performed by 4 different surgeons. Eur Urol 43 (2003) 622-626
57. Smith Jr. J.A., Chan R.C., Chang S.S., et al. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol 178 (2007) 2385-2389 Discussion 2389-90
58. Halm E.A., Lee C., and Chassin M.R. Is volume related to outcome in health care?. A systematic review and methodological critique of the literature. Ann Intern Med 137 (2002) 511-520
59. Lunacek A., Schwentner C., Fritsch H., et al. Anatomical radical retropubic prostatectomy: 'Curtain dissection' of the neurovascular bundle. BJU Int 95 (2005) 1226-1231
60. Ohori M., Wheeler T.M., Kattan M.W., et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154 (1995) 1818-1824
61. Boccon-Gibod L., Bertaccini A., Bono A.V., et al. Management of locally advanced prostate cancer: A European consensus. Int J Clin Pract 57 (2003) 187-194
62. Marks R.A., Koch M.O., Lopez-Beltran A., et al. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Hum Pathol 38 (2007) 1207-1211
63. Shuford M.D., Cookson M.S., Chang S.S., et al. Adverse prognostic significance of capsular incision with radical retropubic prostatectomy. J Urol 172 (2004) 119-123
64. Ohori M., Kattan M.W., Koh H., et al. Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer. J Urol 171 (2004) 1844-1849
65. Shah O., Robbins D.A., Melamed J., et al. The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. J Urol 169 (2003) 2147-2152
66. Vickers A.J., Bianco F.J., Serio A.M., et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 99 (2007) 1171-1177
67. Vickers A.J., Bianco F.J., Gonen M., et al. Effects of pathologic stage on the learning curve for radical prostatectomy: Evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol 53 (2008) 960-966
68. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
69. Grossfeld G.D., Chang J.J., Broering J.M., et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: Data from the CaPSURE database. J Urol 163 (2000) 1171-1177
70. Paulson D.F., Moul J.W., and Walther P.J. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: Long-term results. J Urol 144 (1990) 1180-1184
71. Karakiewicz P.I., Eastham J.A., Graefen M., et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5,831 patients. Urology 66 (2005) 1245-1250
72. Fesseha T., Sakr W., Grignon D., et al. Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol 158 (1997) 2176-2179
73. Eastham J.A., Kuroiwa K., Ohori M., et al. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology 70 (2007) 965-969
74. Koppie T.M., Bianco Jr. F.J., Kuroiwa K., et al. The clinical features of anterior prostate cancers. BJU Int 98 (2006) 1167-1171
75. Poulos C.K., Koch M.O., Eble J.N., et al. Bladder neck invasion is an independent predictor of prostate-specific antigen recurrence. Cancer 101 (2004) 1563-1568
76. Aydin H., Tsuzuki T., Hernandez D., et al. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression. Urology 64 (2004) 551-555
77. Bianco F.J., Grignon D.J., Sakr W.A., et al. Radical prostatectomy with bladder neck preservation: Impact of a positive margin. Urology 64 (2004) 551-555
78. Yossepowitch O., Sircar K., Scardino P.T., et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol 168 (2002) 2011-2015
79. Stolzenburg J.U., Rabenalt R., Tannapfel A., et al. Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Urology 67 (2006) 17-21
80. Barocas D.A., Han M., Epstein J.I., et al. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?. Urology 58 (2001) 746-751
81. Pinto F., Prayer-Galetti T., Gardiman M., et al. Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer. Urol Int 76 (2006) 202-208
82. Swindle P., Eastham J.A., Ohori M., et al. Do margins matter?. The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 174 (2005) 903-907
83. Watson R.B., Civantos F., and Soloway M.S. Positive surgical margins with radical prostatectomy: Detailed pathological analysis and prognosis. Urology 48 (1996) 80-90
84. D'Amico A.V., Whittington R., Malkowicz S.B., et al. An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: Implications on the use of adjuvant therapy. Urology 47 (1996) 538-547
85. Epstein J.I., Pizov G., and Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71 (1993) 3582-3593
86. Paulson D.F., Stone A.R., Walther P.J., et al. Radical prostatectomy: Anatomical predictors of success or failure. J Urol 136 (1986) 1041-1043
87. Weldon V.E., Tavel F.R., Neuwirth H., et al. Failure of focal prostate cancer on biopsy to predict focal prostate cancer: The importance of prevalence. J Urol 154 (1995) 1074-1077
88. Blute M.L., Bostwick D.G., Seay T.M., et al. Pathologic classification of prostate carcinoma: The impact of margin status. Cancer 82 (1998) 902-908
89. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
90. Thompson Jr. I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA 296 (2006) 2329-2335
91. Leventis A.K., Shariat S.F., Kattan M.W., et al. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 19 (2001) 1030-1039
92. Catton C., and Milosevic M. Salvage radiotherapy following radical prostatectomy. World J Urol 21 (2003) 243-252
93. Stephenson A.J., Scardino P.T., Kattan M.W., et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25 (2007) 2035-2041
94. Messing E.M., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
95. Bolla M., Descotes J.L., Artignan X., et al. Adjuvant treatment to radiation: Combined hormone therapy and external radiotherapy for locally advanced prostate cancer. BJU Int 100 Suppl 2 (2007) 44-47
96. Studer U.E., Whelan P., Albrecht W., et al. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organization for Research and Treatment of Cancer (EORTC) Trial 30891. J Clin Oncol 24 (2006) 1868-1876
97. Iversen P., Johansson J.E., Lodding P., et al., Scandinavian Prostate Cancer Group. Bicalutamide 150 mg in addition to standard care for patients with early nonmetastatic prostate cancer: Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years. Scand J Urol Nephrol 40 (2006) 441-452
98. Parker C., Clarke N., Logue J., et al., The RADICALS Trial Management Group. RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). Clin Oncol (R Coll Radiol) 19 (2007) 167-171